Close Menu

NEW YORK (GenomeWeb News) – Millipore will be the worldwide distributor of the ACTCellerate human progenitor cell lines under a co-marketing agreement signed with BioTime subsidiary Embryome Sciences, BioTime said yesterday.

The ACTCellerate line is derived from human embryonic stem cells but not fully differentiated into specific cell types and are used in drug discovery, research, and development. BioTime said that the cell lines are generated using a two-step multiplex process that rapidly isolates and purifies progenitor cells from different lineages.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.